En Es
Categorías

EUROIMMUN AG

Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
Miembro Oro
Productos Covid-19Resumen
Close

Covid-19 EUROIMMUN AG

Laboratorio clínico

SARS-CoV-2 sVNT Test
SARS-CoV-2-NeutraLISA

The SARS-CoV-2-NeutraLISA is a surrogate virus neutralization test (sVNT) for the semi-quantitative detection of neutralizing antibodies inhibiting the binding of SARS-CoV-2 S1/RBD to ACE2 receptors of the host cells. It supports the evaluation of the immune response after SARS-CoV-2 infection or vaccination using S1/RBD-based vaccines.
Mas detalles

SARS-CoV-2 IGRA
SARS-CoV-2 IGRA

The SARS-CoV-2 IGRA is an interferon-gamma release assay (IGRA) for the quantitative determination of the IFN-γ release of SARS-CoV-2-specific T cells.
Mas detalles

EXTRACTOR DE ÁCIDO NUCLEICO
Pre-NAT II

El Pre-NAT II permite la preparación totalmente automatizada, de muestras de alto rendimiento para el diagnóstico genético molecular, que consiste en la extracción de ácido nucleico y el posterior pipeteo de las PCR.
Mas detalles

SARS-CoV-2 PCR Test
EURORealTime SARS-CoV-2

EURORealTime SARS-CoV-2 is a PCR test for the specific detection ofSARS-CoV-2, including the new variants VOC 202012/01 (B.1.1.7 lineage) and 501.V2 (B.1.351 lineage). The test enables quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step, and has high sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences.
Mas detalles

SARS-CoV-2/Influenza A/B PCR Test
EURORealTime SARS-CoV-2/Influenza A/B

EURORealTime SARS-CoV-2/Influenza A/B is a reliable PCR test for the specific detection of SARS-CoV-2, including the new variants VOC202012/01 (B.1.1.7 lineage) and 501.V2 (B.1.351 lineage) as well as of influenza virus types A and B. It enables quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step, and is intended for differential diagnostic clarification of symptoms that can be associated with COVID-19 as well as influenza.
Mas detalles

SARS-CoV-2 Antigen ELISA
SARS-CoV-2 Antigen ELISA

SARS-CoV-2 Antigen ELISA is a laboratory diagnostic test for the direct detection of SARS-CoV-2 by semi-quantitative determination of the virus-specific nucleocapsid protein in swab samples from the upper respiratory tract. Designed to support acute diagnostics, especially during a COVID-19 outbreak, the test is based on the established ELISA method, making it suitable for every diagnostic laboratory and is fully automatable.
Mas detalles

Anti-SARS-CoV-2 ELISA IgG
Anti-SARS-CoV-2 ELISA IgG

The Anti-SARS-CoV-2 ELISA IgG is intended for the specific detection of IgG against SARS-CoV-2 using the S1 domain of the spike protein, including the immunologically relevant receptor binding domain (RBD). Its excellent performance and good correlation with neutralization tests has been confirmed in external studies, and the fully automatable test has been validated for serum, plasma and dried capillary blood as the sample material.
Mas detalles

Anti-SARS-CoV-2 ELISA (IgG)
Anti-SARS-CoV-2 QuantiVac ELISA (IgG)

The Anti-SARS-CoV-2 QuantiVac ELISA (IgG) is a quantitative ELISA for the determination of concentration of IgG antibodies against the S1 antigen (incl. RBD) of SARS-CoV-2 in a broad linear range (using a 6-point calibration curve). Validated for serum, plasma and dried capillary blood as sample material, the test enables issuing of results in standardized units and demonstrates very good agreement of results in comparison with different neutralization tests.
Mas detalles

Anti-SARS-CoV-2 NCP ELISA (IgG)
Anti-SARS-CoV-2 NCP ELISA (IgG)

Anti-SARS-CoV-2 NCP ELISA (IgG) is intended for the sensitive detection of IgG against SARS-CoV-2 using the nucleocapsid protein, the antigen with the strongest immune dominance in the coronavirus family. The fully automatable test offers optimized specificity of the ELISA due to the use of a modified nucleocapsid protein (NCP) that only contains diagnostically relevant epitopes and has been validated for serum, plasma and dried capillary blood as sample material.
Mas detalles

Anti-SARS-CoV-2 NCP ELISA (IgM)
Anti-SARS-CoV-2 NCP ELISA (IgM)

Anti-SARS-CoV-2 NCP ELISA (IgM) is intended for the sensitive detection of IgM against SARS-CoV-2 using the nucleocapsid protein, the antigen with the strongest immune dominance in the coronavirus family. It offers optimized specificity of the ELISA due to the use of a modified nucleocapsid protein (NCP) that only contains diagnostically relevant epitopes, and allows for fully automated processing and evaluation.
Mas detalles

Anti-SARS-CoV-2 ELISA IgA
Anti-SARS-CoV-2 ELISA IgA

Anti-SARS-CoV-2 ELISA IgA is a sensitive ELISA test for the determination of IgA antibodies against SARS-CoV-2 with optimized specificity due to the use of sample buffer PLUS. It makes use of the spike protein domain S1 as the antigen for monitoring the immune response after positive direct pathogen detection, and makes fully automated processing and evaluation possible.
Mas detalles

Blood Collection Set
Blood Collection Set

Euroimmun’s Blood Collection Set for COVID-19 diagnostics using dried capillary blood enables convenient sample collection for the company’s CE-marked ELISAs for the detection of anti-SARS-CoV-2 antibodies (IgG). The use of dried blood spots (DBS) as sample material reduces the blood collection to a quick prick into the fingertip, sparing patients the burdensome and stressful collection of venous blood. The blood spot is brought onto the blood collection card and after drying, it can be sent to the laboratory immediately. All the required materials are included in the EUROIMMUN Blood Collection Set, including alcohol pad, lancet, blood collection card and plasters, while the blood collection cards can also be purchased separately.
Mas detalles

ELISA PROCESSOR
EUROIMMUN Analyzer I-2P

El analizador I-2P de Euroimmun permite una rutina de operación rápida, simple y segura debido al reconocimiento automático y distribución de los reactivos y a la importación de datos de control de calidad vía códigos de matriz de datos.
Mas detalles

PCR Y ELISA PARA LA COVID-19
COVID-19 PCR and ELISAs

El portafolio de EUROIMMUN para el diagnóstico de COVID19 incluye el EURORealTime SARS-CoV-2, para la detección directa, sensible, del virus, así como los ELISA basados en el dominio de la proteína spike S1 (IgG, IgA) o la proteína modificada de la nucleocápside (NCP, IgG).
Mas detalles
Close

Sobre EUROIMMUN AG

Número de empleados: 1000+
Año de establecimiento 1987
Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
Facebook Twitter Google+ Linked in
Anti-SARS-CoV-2 NCP ELISA (IgG)

Anti-SARS-CoV-2 NCP ELISA (IgG)

Modelo: Anti-SARS-CoV-2 NCP ELISA (IgG)
Solicite información

Descripción:

Anti-SARS-CoV-2 NCP ELISA (IgG) is intended for the sensitive detection of IgG against SARS-CoV-2 using the nucleocapsid protein, the antigen with the strongest immune dominance in the coronavirus family. The fully automatable test offers optimized specificity of the ELISA due to the use of a modified nucleocapsid protein (NCP) that only contains diagnostically relevant epitopes and has been validated for serum, plasma and dried capillary blood as sample material.

Características: Especificaciones:

Características:

• Sensitive detection of IgG antibodies against SARS-CoV-2 using the nucleocapsid protein
• Antigen with the strongest immune dominance in the coronavirus family
• Optimized specificity of the ELISA due to the use of a modified nucleocapsid protein (NCP) that only contains diagnostically relevant epitopes
• Validated for serum, plasma and dried capillary blood (DBS only in combination with the IgG ELISA) as sample material, complete automation possible Solicite información

Especificaciones:

• Antigen: Modified nucleocapsid protein (NCP)
• Calibration: Semi-quantitative; calculation of a ratio from the extinction of the sample and that of the calibrator
• Result interpretation: EUROIMMUN recommends interpreting results as follows: Ratio < 0.8: negative; Ratio ≥ 0.8 to< 1.1: borderline; Ratio≥ 1.1: positive
• Sample dilution: Serum or plasma, 1 : 101 in sample buffer, or 4.76 mm punched out membrane piece with dried capillary blood in 250 μl sample buffer
• Reagents: Ready for use, with the exception of the wash buffer (10x); color-coded solutions, in most cases exchangeable with those in other EUROIMMUN ELISA kits
• Test procedure: 60 min (37° C) / 30 min (RT) / 15 min (RT) (sample / conjugate / substrate incubations), fully automatable
• Measurement: 450 nm, reference wavelength between 620 nm and 650 nm
• Test kit format: 96 break-off wells; kit includes all necessary reagents
• Stability: 12 months Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
EUROIMMUN AG ()
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones